{"ATC Code":"N02CC06","Abbreviation":"","Aliases":["eletriptanum","UK 116044","UK-116044","UK-116,044","Uk-116044-04 free base","3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole","Uk-116,044-04 free base","1H-Indole, 3-(((2R)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)ethyl)-","3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole","(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole"],"Biological Half-Life":"The terminal elimination half-life of eletriptan is approximately 4 hours.","CAS":"143322-58-1","ChEBI":"CHEBI:50922","ChEMBL":"CHEMBL1510","ChemicalClasses":["tryptamine"],"Chirality":"absolute","Classes":null,"Drug Classes":"Breast Feeding; Lactation; Milk, Human; Serotonin Receptor Agonists; Serotonin 5-HT1 Receptor Agonists; Triptans; Vasoconstrictor Agents","Drug Indication":"For the acute treatment of migraine with or without aura in adults.","DrugClasses":["antidepressant","depressant"],"EliminationHalfLife":"4 hours","European Community (EC) Number":"640-088-3","FDA Pharmacological Classification":"22QOO9B8KI","FullSalts":["Eletriptan hydrobromide","Eletriptan mesylate","Eletriptan succinate","Eletriptan hydrochloride","Eletriptan hemisulfate"],"HMDB ID":"HMDB0014361","HeavyAtomCount":27,"Human Drugs":"Breast Feeding; Lactation; Milk, Human; Serotonin Receptor Agonists; Serotonin 5-HT1 Receptor Agonists; Triptans; Vasoconstrictor Agents","IUPACName":"5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole","InChI":"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1","InChIKey":"PWVXXGRKLHYWKM-LJQANCHMSA-N","MeSH Pharmacological Classification":"Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)","MolecularFormula":"C\u003csub\u003e22\u003c/sub\u003eH\u003csub\u003e26\u003c/sub\u003eN\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e2\u003c/sub\u003eS","MolecularWeight":"382.5 g/mol","Opticalactivity":"UNSPECIFIED","Pharmacodynamics":"Eletriptan is a selective 5-hydroxytryptamine 1B/1D receptor agonist. In the anesthetized dog, eletriptan has been shown to reduce carotid arterial blood flow, with only a small increase in arterial blood pressure at high doses. While the effect on blood flow was selective for the carotid arterial bed, decreases in coronary artery diameter were observed. Eletriptan has also been shown to inhibit trigeminal nerve activity in the rat.","Physical Description":"Solid","PrevSalts":["hydrobromide","mesylate","succinate","hydrochloride","hemisulfate"],"PubChemId":77993,"Record Description":["Eletriptan is an N-alkylpyrrolidine, that is N-methylpyrrolidine in which the pro-R hydrogen at position 2 is replaced by a {5-[2-(phenylsulfonyl)ethyl]-1H-indol-3-yl}methyl group. It has a role as a serotonergic agonist, a vasoconstrictor agent and a non-steroidal anti-inflammatory drug. It is a member of indoles, a N-alkylpyrrolidine and a sulfone. It is a conjugate base of an eletriptan(1+).","Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.","Eletriptan is a Serotonin-1b and Serotonin-1d Receptor Agonist. The mechanism of action of eletriptan is as a Serotonin 1b Receptor Agonist, and Serotonin 1d Receptor Agonist.","ELETRIPTAN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for migraine disorder and has 2 investigational indications.","See also: Eletriptan Hydrobromide (has salt form); Eletriptan hydrobromide monohydrate (active moiety of).","Eletriptan is an N-alkylpyrrolidine, that is N-methylpyrrolidine in which the pro-R hydrogen at position 2 is replaced by a {5-[2-(phenylsulfonyl)ethyl]-1H-indol-3-yl}methyl group. It has a role as a serotonergic agonist, a vasoconstrictor agent and a non-steroidal anti-inflammatory drug. It is a member of indoles, a N-alkylpyrrolidine and a sulfone. It is a conjugate base of an eletriptan(1+).","LiverTox|CNS|Migraine|5HT-1 receptor agonist"],"RefCount":4,"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Eletriptan","Name":"Eletriptan","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q415032","Name":"Eletriptan","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB00216","Name":"Eletriptan","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/77993","Name":"Eletriptan","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1510","Name":"Eletriptan","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:50922","Name":"Eletriptan","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=143322-58-1","Name":"Eletriptan","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0014361","Name":"Eletriptan","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D07887","Name":"Eletriptan","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/22QOO9B8KI","Name":"Eletriptan","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9046861","Name":"Eletriptan","Sub":false}]}],"Refs":["National Center for Biotechnology Information. PubChem Compound Summary for CID 77993, Eletriptan. Accessed July 3, 2025. \u003ca href=https://pubchem.ncbi.nlm.nih.gov/compound/77993\u003ehttps://pubchem.ncbi.nlm.nih.gov/compound/77993\u003c/a\u003e","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Eletriptan. UNII: 22QOO9B8KI. Global Substance Registration System. Accessed July 3, 2025. \u003ca href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/22QOO9B8KI\u003ehttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/22QOO9B8KI\u003c/a\u003e","Relpax 20mg Film-Coated Tablets. - Summary of Product Characteristics (SmPC). July 3, 2020. Accessed July 3, 2025. \u003ca href=https://www.medicines.org.uk/emc/product/1568/smpc\u003ehttps://www.medicines.org.uk/emc/product/1568/smpc\u003c/a\u003e"],"SMILES":"CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4","Salts":["hydrobromide","mesylate","succinate","hydrochloride","hemisulfate"],"SaltsAcidCount":[1,0,1,1,1],"SaltsAmineCount":[1,1,1,1,2],"SaltsUNII":["M41W832TA3","607KP935Y1","92AD31CQ59","OL4Q27AUZF","AMM8PSU28B"],"Scheduling":[{"gov":"Australia","ref":[],"schedule":"S3 \u0026 S4 substance"},{"gov":"Canada","ref":[],"schedule":"prescription only substance"},{"gov":"United Kingdom","ref":["3"],"schedule":"prescription only substance"},{"gov":"United States","ref":[],"schedule":"prescription only substance"}],"Solubility":"Readily soluble as hydrobromide formulation","StoreUNII":["22QOO9B8KI"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="99.274mm" version="1.2" viewBox="0 0 155.257 99.274" width="155.257mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#3050F8" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="100.0" stroke="none" width="156.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="147.266" x2="144.874" y1="56.976" y2="68.055"/>
                  
            <line class="bond" id="mol1bnd2" x1="146.926" x2="154.203" y1="75.078" y2="83.187"/>
                  
            <line class="bond" id="mol1bnd3" x1="154.203" x2="146.594" y1="83.187" y2="96.417"/>
                  
            <line class="bond" id="mol1bnd4" x1="146.594" x2="131.691" y1="96.417" y2="93.231"/>
                  
            <line class="bond" id="mol1bnd5" x1="131.691" x2="130.06" y1="93.231" y2="78.025"/>
                  
            <line class="bond" id="mol1bnd6" x1="140.828" x2="130.06" y1="73.29" y2="78.025"/>
                  
            <g class="bond" id="mol1bnd7">
                        
                <line x1="129.756" x2="130.363" y1="78.199" y2="77.85"/>
                        
                <line x1="127.305" x2="128.418" y1="77.072" y2="76.432"/>
                        
                <line x1="124.854" x2="126.472" y1="75.945" y2="75.014"/>
                        
                <line x1="122.403" x2="124.527" y1="74.818" y2="73.595"/>
                        
                <line x1="119.952" x2="122.582" y1="73.691" y2="72.177"/>
                        
                <line x1="117.501" x2="120.636" y1="72.564" y2="70.759"/>
                        
                <line x1="115.05" x2="118.691" y1="71.436" y2="69.341"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd8" x1="116.871" x2="103.663" y1="70.389" y2="77.992"/>
                  
            <g class="bond" id="mol1bnd9">
                        
                <line x1="102.081" x2="103.663" y1="93.111" y2="77.992"/>
                        
                <line x1="99.841" x2="101.054" y1="91.093" y2="79.494"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd10" x1="102.081" x2="90.521" y1="93.111" y2="95.562"/>
                  
            <line class="bond" id="mol1bnd11" x1="85.083" x2="79.541" y1="92.604" y2="83.069"/>
                  
            <g class="bond" id="mol1bnd12">
                        
                <line x1="79.541" x2="89.739" y1="83.069" y2="71.744"/>
                        
                <line x1="78.672" x2="86.984" y1="80.391" y2="71.159"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd13" x1="103.663" x2="89.739" y1="77.992" y2="71.744"/>
                  
            <line class="bond" id="mol1bnd14" x1="89.739" x2="85.022" y1="71.744" y2="57.243"/>
                  
            <g class="bond" id="mol1bnd15">
                        
                <line x1="85.022" x2="70.108" y1="57.243" y2="54.068"/>
                        
                <line x1="83.138" x2="70.978" y1="59.335" y2="56.746"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd16" x1="70.108" x2="59.91" y1="54.068" y2="65.394"/>
                  
            <g class="bond" id="mol1bnd17">
                        
                <line x1="59.91" x2="64.627" y1="65.394" y2="79.894"/>
                        
                <line x1="62.665" x2="66.511" y1="65.979" y2="77.802"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd18" x1="79.541" x2="64.627" y1="83.069" y2="79.894"/>
                  
            <line class="bond" id="mol1bnd19" x1="70.108" x2="65.401" y1="54.068" y2="39.573"/>
                  
            <line class="bond" id="mol1bnd20" x1="65.401" x2="50.494" y1="39.573" y2="36.402"/>
                  
            <line class="bond" id="mol1bnd21" x1="50.494" x2="46.993" y1="36.402" y2="25.622"/>
                  
            <g class="bond" id="mol1bnd22">
                        
                <line x1="48.513" x2="57.064" y1="20.294" y2="19.093"/>
                        
                <line x1="48.852" x2="57.403" y1="22.708" y2="21.508"/>
                      
                <line class="hi" stroke="#C6C62C" x1="48.513" x2="52.7885" y1="20.294" y2="19.6935"/>
                <line class="hi" stroke="#FF0D0D" x1="57.064" x2="52.7885" y1="19.093" y2="19.6935"/>
                <line class="hi" stroke="#C6C62C" x1="48.852" x2="53.1275" y1="22.708" y2="22.107999999999997"/>
                <line class="hi" stroke="#FF0D0D" x1="57.403" x2="53.1275" y1="21.508" y2="22.107999999999997"/>
            </g>
                  
            <g class="bond" id="mol1bnd23">
                        
                <line x1="44.706" x2="44.966" y1="17.947" y2="10.554"/>
                        
                <line x1="47.143" x2="47.402" y1="18.033" y2="10.64"/>
                      
                <line class="hi" stroke="#C6C62C" x1="44.706" x2="44.836" y1="17.947" y2="14.250499999999999"/>
                <line class="hi" stroke="#FF0D0D" x1="44.966" x2="44.836" y1="10.554" y2="14.250499999999999"/>
                <line class="hi" stroke="#C6C62C" x1="47.143" x2="47.2725" y1="18.033" y2="14.336500000000001"/>
                <line class="hi" stroke="#FF0D0D" x1="47.402" x2="47.2725" y1="10.64" y2="14.336500000000001"/>
            </g>
                  
            <line class="bond" id="mol1bnd24" x1="42.909" x2="30.881" y1="21.295" y2="18.736"/>
                  
            <g class="bond" id="mol1bnd25">
                        
                <line x1="20.68" x2="30.881" y1="30.059" y2="18.736"/>
                        
                <line x1="19.811" x2="28.127" y1="27.38" y2="18.151"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd26" x1="20.68" x2="5.766" y1="30.059" y2="26.879"/>
                  
            <g class="bond" id="mol1bnd27">
                        
                <line x1="1.054" x2="5.766" y1="12.377" y2="26.879"/>
                        
                <line x1="3.809" x2="7.651" y1="12.963" y2="24.787"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd28" x1="1.054" x2="11.256" y1="12.377" y2="1.054"/>
                  
            <g class="bond" id="mol1bnd29">
                        
                <line x1="26.169" x2="11.256" y1="4.234" y2="1.054"/>
                        
                <line x1="24.284" x2="12.124" y1="6.326" y2="3.733"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd30" x1="30.881" x2="26.169" y1="18.736" y2="4.234"/>
                  
            <path class="atom" d="M145.991 74.323h-.72l-2.62 -4.066h-.03q.012 .238 .03 .595q.024 .358 .024 .733v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.578v4.899z" id="mol1atm2" stroke="none"/>
                  
            <g class="atom" id="mol1atm10">
                        
                <path d="M89.152 98.714h-.721l-2.619 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.715l2.607 4.055h.03q-.006 -.108 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.578v4.9z" stroke="none"/>
                        
                <path d="M84.709 98.714h-.619v-2.286h-2.513v2.286h-.613v-4.9h.613v2.072h2.513v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M47.332 23.044q.0 .649 -.476 1.018q-.47 .364 -1.268 .364q-.417 -.0 -.768 -.066q-.345 -.059 -.578 -.173v-.589q.244 .113 .608 .202q.369 .09 .762 .09q.547 -.0 .827 -.215q.28 -.214 .28 -.577q-.0 -.238 -.107 -.399q-.101 -.167 -.351 -.309q-.251 -.143 -.697 -.298q-.625 -.226 -.947 -.554q-.315 -.333 -.315 -.899q-.0 -.393 .196 -.666q.203 -.28 .554 -.429q.357 -.155 .816 -.155q.404 .0 .738 .078q.339 .071 .613 .196l-.196 .53q-.251 -.113 -.548 -.185q-.298 -.077 -.625 -.077q-.459 -.0 -.691 .196q-.232 .197 -.232 .518q.0 .244 .101 .411q.107 .167 .34 .298q.232 .125 .631 .28q.428 .154 .726 .339q.298 .178 .452 .434q.155 .25 .155 .637z" fill="#C6C62C" id="mol1atm19" stroke="none"/>
                  
            <path class="atom" d="M63.138 19.786q.0 .756 -.255 1.327q-.256 .566 -.757 .881q-.5 .316 -1.244 .316q-.756 -.0 -1.262 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.501 .31 .757 .875q.255 .566 .255 1.328zM59.275 19.786q-.0 .923 .387 1.458q.393 .53 1.22 .53q.84 .0 1.221 -.53q.387 -.535 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" fill="#FF0D0D" id="mol1atm20" stroke="none"/>
                  
            <path class="atom" d="M48.581 6.674q-.0 .756 -.256 1.327q-.256 .566 -.756 .881q-.5 .316 -1.244 .316q-.757 -.0 -1.263 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.733 -.0 1.233 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM44.717 6.674q.0 .923 .387 1.458q.393 .53 1.221 .53q.839 .0 1.22 -.53q.387 -.535 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" fill="#FF0D0D" id="mol1atm21" stroke="none"/>
                
            <line class="hi" id="mol1bnd1" stroke="#3050F8" x1="144.874" x2="146.07" y1="68.055" y2="62.5155"/>
            <line class="hi" id="mol1bnd2" stroke="#3050F8" x1="146.926" x2="150.5645" y1="75.078" y2="79.1325"/>
            <line class="hi" id="mol1bnd6" stroke="#3050F8" x1="140.828" x2="135.44400000000002" y1="73.29" y2="75.6575"/>
            <line class="hi" id="mol1bnd10" stroke="#3050F8" x1="90.521" x2="96.301" y1="95.562" y2="94.3365"/>
            <line class="hi" id="mol1bnd10" stroke="#3050F8" x1="90.521" x2="96.301" y1="95.562" y2="94.3365"/>
            <line class="hi" id="mol1bnd11" stroke="#3050F8" x1="85.083" x2="82.312" y1="92.604" y2="87.8365"/>
            <line class="hi" id="mol1bnd11" stroke="#3050F8" x1="85.083" x2="82.312" y1="92.604" y2="87.8365"/>
            <line class="hi" id="mol1bnd21" stroke="#C6C62C" x1="46.993" x2="48.7435" y1="25.622" y2="31.012"/>
            <line class="hi" id="mol1bnd24" stroke="#C6C62C" x1="42.909" x2="36.894999999999996" y1="21.295" y2="20.015500000000003"/>
        </g>
          
    </g>
    
</svg>
","Subjective Effects":null,"Title":"Eletriptan","UNII":"22QOO9B8KI","Wikidata":"Q415032","Wikipedia":"Eletriptan","XLogP":4.1}